Cargando…

Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials

BACKGROUND: Hyperglycemia is associated with an increased risk of developing atrial fibrillation (AF) and atrial flutter (AFL). Sodium-glucose transporter 2 inhibitors (SGLT2i) have been reported to prevent AF/AFL in some studies, but not others. Therefore, a meta-analysis was performed to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Daobo, Liu, Yingying, Hidru, Tesfaldet Habtemariam, Yang, Xiaolei, Wang, Yunsong, Chen, Cheng, Li, Ka Hou Christien, Tang, Yuqi, Wei, Yushan, Tse, Gary, Xia, Yunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018283/ https://www.ncbi.nlm.nih.gov/pubmed/33815278 http://dx.doi.org/10.3389/fendo.2021.619586

Ejemplares similares

Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation
por: Wang, Shihao, et al.
Publicado: (2021)

Does Serum Uric Acid Status Influence the Association Between Left Atrium Diameter and Atrial Fibrillation in Hypertension Patients?
por: Hidru, Tesfaldet H., et al.
Publicado: (2020)

Nomogram to Predict Left Atrial Thrombus or Spontaneous Echo Contrast in Patients With Non-valvular Atrial Fibrillation
por: Li, Zhitong, et al.
Publicado: (2021)

Long Atrial Fibrillation Duration and Early Recurrence Are Reliable Predictors of Late Recurrence After Radiofrequency Catheter Ablation
por: Li, Zhitong, et al.
Publicado: (2022)

Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
por: Li, Zhitong, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Estimation of Left Atrial Thrombus or Spontaneous Echo Contrast Risk in Non-Valvular Atrial Fibrillation Patients with Low to Borderline CHA(2)DS(2)-VASc Score
por: Li, Zhitong, et al.
Publicado: (2022)

Stress hyperglycemia ratio and neutrophil to lymphocyte ratio are reliable predictors of new-onset atrial fibrillation in patients with acute myocardial infarction
por: Pan, Lifei, et al.
Publicado: (2022)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

The relationship between Plasma Markers and Essential Hypertension in Middle-aged and Elderly Chinese Population: A Community Based Cross-sectional Study
por: Hidru, Tesfaldet Habtemariam, et al.
Publicado: (2019)

Sinus node dysfunction and stroke risk: a systematic review and meta-analysis
por: Dong, Haoyu, et al.
Publicado: (2023)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010)

Predictors of the Atrial Fibrillation Following Catheter Ablation of Typical Atrial Flutter.
por: Haghjoo, Majid, et al.
Publicado: (2013)

Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter
por: Stempfel, Samuel, et al.
Publicado: (2020)

The Short QTc Is a Marker for the Development of Atrial Flutter and Atrial Fibrillation
por: Rabkin, Simon W., et al.
Publicado: (2020)

Epi-endocardial asynchrony during atrial flutter followed by atrial fibrillation
por: van Staveren, Lianne N., et al.
Publicado: (2021)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Risk assessment of pre-excitation: Atrial fibrillation versus atrial flutter
por: Uniat, Jonathan, et al.
Publicado: (2022)

Ehrlichiosis-Induced Atrial Flutter: An Unusual Cause of Atrial Flutter
por: Kunnumpurath, Anthony, et al.
Publicado: (2020)

Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
por: Malviya, Amit, et al.
Publicado: (2020)

Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter
por: Hu, Wei-Syun, et al.
Publicado: (2020)

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter
por: Wybraniec, Maciej T., et al.
Publicado: (2022)

Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter
por: Mont, Lluís, et al.
Publicado: (2009)

Atrial Fibrillation and Atrial Flutter in Pregnant Women—A Population‐Based Study
por: Lee, Ming‐Sum, et al.
Publicado: (2016)

Atrial flutter with alternating tachycardia cycle length after atrial fibrillation ablation
por: Ishimura, Masayuki, et al.
Publicado: (2020)

Cerebrovascular accidents differ between patients with atrial flutter and patients with atrial fibrillation
por: Staszewski, Jacek, et al.
Publicado: (2019)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
por: Christiansen, Christine Benn, et al.
Publicado: (2010)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011)

CHA(2)DS(2)-VASc Score as a Predictor of New-Onset Atrial Fibrillation After Catheter Ablation of Typical Atrial Flutter
por: Liu, Fei, et al.
Publicado: (2020)

The Relationship Between Serum Uric Acid at Different Concentrations of Lipid Indices and the Risk of Myocardial Revascularization in Patients With Acute Coronary Syndrome: A Retrospective Analysis
por: Lin, Yajuan, et al.
Publicado: (2021)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

Cardiac MRI predictors for development of atrial fibrillation or flutter in patients with hypertrophic cardiomyopathy
por: She, Helen Hoi Lam, et al.
Publicado: (2015)

Crucial role of pulmonary vein firing as an initiator of typical atrial flutter: Evidence of a close relationship between atrial fibrillation and typical atrial flutter
por: Kaneshiro, Takashi, et al.
Publicado: (2017)

Atrial fibrillation and its determinants after radiofrequency ablation of chronic common atrial flutter
por: Cade, Stéphane, et al.
Publicado: (2005)

A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter
por: Warchoł, Izabela, et al.
Publicado: (2019)

An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter
por: Sandhu, Roopinder K., et al.
Publicado: (2019)

Prevalence and Risk Factors for Preprocedural Medication Errors in Patients With Atrial Fibrillation and Atrial Flutter
por: Tuttle, Mark K., et al.
Publicado: (2021)

Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis
por: Xie, Xinxing, et al.
Publicado: (2018)

The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS
por: Naccarelli, Gerald V, et al.
Publicado: (2014)

Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019
por: Dong, Xin-Jiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d80eki5n1v6es1iac5t97f9602